The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Fatty Liver, Alcoholic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fatty Liver, Alcoholic


High impact information on Fatty Liver, Alcoholic


Chemical compound and disease context of Fatty Liver, Alcoholic


Biological context of Fatty Liver, Alcoholic


Anatomical context of Fatty Liver, Alcoholic


Gene context of Fatty Liver, Alcoholic


Analytical, diagnostic and therapeutic context of Fatty Liver, Alcoholic


  1. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. You, M., Considine, R.V., Leone, T.C., Kelly, D.P., Crabb, D.W. Hepatology (2005) [Pubmed]
  2. Plasma amino-acid patterns in liver disease. Morgan, M.Y., Marshall, A.W., Milsom, J.P., Sherlock, S. Gut (1982) [Pubmed]
  3. Single-dose ceftriaxone kinetics in liver insufficiency. Stoeckel, K., Tuerk, H., Trueb, V., McNamara, P.J. Clin. Pharmacol. Ther. (1984) [Pubmed]
  4. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. Huang, Y.S., Chan, C.Y., Wu, J.C., Pai, C.H., Chao, Y., Lee, S.D. J. Hepatol. (1996) [Pubmed]
  5. Retinol and retinyl esters in patients with alcoholic liver disease. Bell, H., Nilsson, A., Norum, K.R., Pedersen, L.B., Raknerud, N., Rasmussen, M. J. Hepatol. (1989) [Pubmed]
  6. Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. Tahara, M., Matsumoto, K., Nukiwa, T., Nakamura, T. J. Clin. Invest. (1999) [Pubmed]
  7. The role of AMP-activated protein kinase in the action of ethanol in the liver. You, M., Matsumoto, M., Pacold, C.M., Cho, W.K., Crabb, D.W. Gastroenterology (2004) [Pubmed]
  8. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Tomita, K., Azuma, T., Kitamura, N., Nishida, J., Tamiya, G., Oka, A., Inokuchi, S., Nishimura, T., Suematsu, M., Ishii, H. Gastroenterology (2004) [Pubmed]
  9. Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat? Anania, F.A. Hepatology (2005) [Pubmed]
  10. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P.A., Moser, A.B., Desimone, C., Song, X.Y., Diehl, A.M. Hepatology (2003) [Pubmed]
  11. The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beings. Day, C.P., James, O.F., Brown, A.S., Bennett, M.K., Fleming, I.N., Yeaman, S.J. Hepatology (1993) [Pubmed]
  12. Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver: comparison with other liver enzymes in man and rats. Teschke, R., Neuefeind, M., Nishimura, M., Strohmeyer, G. Gut (1983) [Pubmed]
  13. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function? Stefanini, G.F., Addolorato, G., Caputo, F., Bernardi, M., Gasbarrini, G. J. Hepatol. (1999) [Pubmed]
  14. Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Zhou, S.L., Gordon, R.E., Bradbury, M., Stump, D., Kiang, C.L., Berk, P.D. Hepatology (1998) [Pubmed]
  15. Activities and subcellular distributions of hepatic lipases in control subjects and in patients with alcoholic fatty liver. Leung, N.N., Cairns, S.R., Peters, T.J. Clin. Sci. (1985) [Pubmed]
  16. Effects of cysteine and antioxidants on the hepatic redox-state, acetaldehyde and triglyceride levels after acute ethanol dosing. Ryle, P.R., Chakraborty, J., Thomson, A.D. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement. (1987) [Pubmed]
  17. beta-Oxidation in human alcoholic and non-alcoholic hepatic steatosis. Eaton, S., Zaitoun, A.M., Record, C.O., Bartlett, K. Clin. Sci. (1996) [Pubmed]
  18. Liquid diet technique of ethanol administration: 1989 update. Lieber, C.S., DeCarli, L.M. Alcohol Alcohol. (1989) [Pubmed]
  19. Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver. Lukivskaya, O.Y., Maskevich, A.A., Buko, V.U. Alcohol (2001) [Pubmed]
  20. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. Fischer, M., You, M., Matsumoto, M., Crabb, D.W. J. Biol. Chem. (2003) [Pubmed]
  21. Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. Chen, W.X., Li, Y.M., Yu, C.H., Cai, W.M., Zheng, M., Chen, F. World J. Gastroenterol. (2002) [Pubmed]
  22. Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat. Yamada, S., Iida, T., Tabata, T., Nomoto, M., Kishikawa, H., Kohno, K., Eto, S. Hepatology (2000) [Pubmed]
  23. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. Caballería, J., Parés, A., Brú, C., Mercader, J., García Plaza, A., Caballería, L., Clemente, G., Rodrigo, L., Rodés, J. J. Hepatol. (1998) [Pubmed]
  24. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. de Oliveira, C.P., Simplicio, F.I., de Lima, V.M., Yuahasi, K., Lopasso, F.P., Alves, V.A., Abdalla, D.S., Carrilho, F.J., Laurindo, F.R., de Oliveira, M.G. World J. Gastroenterol. (2006) [Pubmed]
  25. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Gao, B. Alcohol (2004) [Pubmed]
WikiGenes - Universities